Concepedia

Publication | Open Access

The Toll–Like Receptor 2/6 Agonist, FSL–1 Lipopeptide, Therapeutically Mitigates Acute Radiation Syndrome

36

Citations

37

References

2017

Year

References

YearCitations

Page 1